GSK3B and myocardial infarction: Gomez et al. [35] found that mice containing a mutant form of GSK-3β (which cannot be phosphorylated and inhibited) were resistant to the myocardial infarct-limiting effects of Ipost in situ, suggesting that GSK-3β inactivation is required for Ipost's myocardial protection.